Bay Area Natera Sets Terms for $100 Million IPO

Natera, which sells non-invasive prenatal DNA tests, announced terms for its IPO on Monday.

The San Carlos, CA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the midpoint of the proposed range, Natera would command a fully diluted market value of $848 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news